Join industry titans, homegrown innovators, and post-secondary leaders as we address the challenges hindering our region's $27.4B life sciences sector and explore opportunities and solutions to catalyze growth, elevate economic contributions, and advance health outcomes.
Featured Speakers
-
Travis McCready
Head of Life Sciences, Americas Markets Chair, Global Life Sciences Advisory Board
JLL
-
James Brodie
General Manager
Johnson & Johnson MedTech, Canada
-
Carol MacDonald
Co-Founder and President
Gotcare
-
Arthur Kesisyan
VP, Life Sciences Canada
AtkinsRéalis
With $27.4B in GDP contributions, 89K employees, and $1.2B in pharma-related R&D, the life sciences sector in Ontario has a strong strategic and economic presence. However, despite the sector’s strengths, the Toronto region is lagging relative to our peer jurisdictions. Held back by the inability to commercialize, scale, or economically benefit directly from our own innovation, products or services, our life sciences economy and health outcomes will fall short.
Life Sciences – Can Toronto be the Next Boston? is a forum for open dialogue and discussion to unpack Toronto region's life science sector and catalyze its growth. This half-day event will draw on the insights and expertise of a range of players in the ecosystem, including established multinationals, fast-growing home-grown companies, post-secondary institutions, and innovators.
Join us for an engaging program that will help you better understand the sector's challenges, how to leverage opportunities for your business, and its potential to contribute to economic growth, innovation, and good jobs in the Toronto Region and better health outcomes for Canadians.
Individual:
- Member: $149
- Non-Member: $229
Table of 10:
- Member: $1,490
- Non-Member: $2,290